NRx Pharmaceuticals, Inc.
NASDAQ:NRXP
2.1 (USD) • At close April 28, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 1.443 | 4.595 | 20.054 | 27.605 | 1.859 | 0 | 0.011 | 0.449 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 5.968 | 32.005 | 70.766 | 69.029 |
| Cash and Short Term Investments
| 1.443 | 4.595 | 20.054 | 27.605 | 1.859 | 0 | 0.011 | 0.449 |
| Net Receivables
| 0 | 0.006 | 0 | 0 | 0.831 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | -0.007 | 0 | 0.214 | 0 | 0 | 0 |
| Other Current Assets
| 1.859 | 2.283 | 11.482 | 5.109 | 0.24 | 0.069 | 0.019 | 0.087 |
| Total Current Assets
| 3.302 | 6.884 | 25.795 | 32.714 | 2.93 | 0.069 | 0.03 | 0.536 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 32.005 | 70.766 | 69.029 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.349 | 0.431 | 0.021 | 0.015 | 0.011 | 0 | 0 | 0 |
| Total Non-Current Assets
| 0.349 | 0.431 | 0.021 | 0.015 | 0.011 | 32.005 | 70.766 | 69.029 |
| Total Assets
| 3.651 | 7.315 | 25.816 | 32.729 | 2.941 | 32.075 | 70.796 | 69.566 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 4.13 | 4.632 | 2.076 | 3.687 | 3.153 | 0.622 | 0.551 | 0.086 |
| Short Term Debt
| 1.566 | 9.161 | 7.703 | 0.518 | 0.249 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0.052 | 0.069 | 0.016 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 2.844 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 16.167 | 5.255 | 5.806 | 7.718 | 42.71 | -0.069 | 0 | 0.008 |
| Total Current Liabilities
| 21.863 | 19.048 | 16.585 | 11.923 | 46.164 | 0.622 | 0.567 | 0.093 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 5.011 | 0 | 2.822 | 0 | 0.548 | 1.952 | 0.69 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 5.011 | 0 | 1.822 | 0 | 0.548 | 1.952 | 0.69 | 0 |
| Total Liabilities
| 26.874 | 19.048 | 18.407 | 11.923 | 46.712 | 2.574 | 1.257 | 0.093 |
| Equity: | ||||||||
| Preferred Stock
| 0 | 0.003 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 0.015 | 0.084 | 0.067 | 0.059 | 0.043 | 24.503 | 64.541 | 64.475 |
| Retained Earnings
| -278.273 | -253.147 | -223.059 | -183.243 | -90.18 | 0.369 | -0.039 | -0.105 |
| Accumulated Other Comprehensive Income/Loss
| 0 | -0.003 | 0 | 0 | 0 | -24.503 | 0 | 0 |
| Other Total Stockholders Equity
| 255.035 | 241.33 | 230.339 | 203.99 | 46.366 | 4.628 | 5.036 | 5.102 |
| Total Shareholders Equity
| -23.223 | -11.733 | 7.409 | 20.806 | -43.771 | 29.5 | 69.539 | 69.473 |
| Total Equity
| -23.223 | -11.733 | 7.409 | 20.806 | -43.771 | 29.5 | 69.539 | 69.473 |
| Total Liabilities & Shareholders Equity
| 3.651 | 7.315 | 25.816 | 32.729 | 2.941 | 32.075 | 70.796 | 69.566 |